Administration of propylactic tocilizumab, overall response rates, and rates of CRS and ICANS.
Figure 1.

Administration of propylactic tocilizumab, overall response rates, and rates of CRS and ICANS.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal